Stay updated on Atezolizumab Combo in Esophageal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page.

Latest updates to the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page’s revision/version label has been updated from **v3.5.2** to **v3.5.3**, reflecting a website release rather than a change to the trial record itself.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoChange DetectedAdded new study locations (e.g., The First Affiliated Hospital to Henan University of Science and Technology in Luoyang; Harbin Medical University Cancer Hospital; The First People’s Hospital of Foshan; The First Hospital of Jilin University in Changchun) bringing the total to 68 locations, and updated the results status with 'Results Posted' and related definitions.SummaryDifference3%

- Check40 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded a 'Results Submitted' status and updated the page to Revision: v3.4.2, replacing the prior 'No Results Posted' notice and the earlier v3.4.1 revision.SummaryDifference0.3%

Stay in the know with updates to Atezolizumab Combo in Esophageal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page.